Hsa-miR29b, a critical downstream target of noncanonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression

Biology Open

Volumn 2, Issue 7, 2013, Pages 675-685

  Avasarala, Sreedevi ^a   Van Scoyk, Michelle ^a   Wang, Jianbin ^a   Sechler, Marybeth ^a   Vandervest, Katherine ^a   Brzezinski, Christine ^a   Weekes, Colin ^a   Edwards, Michael G ^a   Arcaroli, John ^a   Davis, Richard E ^a   Bikkavilli, Rama Kamesh ^a   Winn, Robert A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Frizzled 9; Hsa miR29b; MDM2; Non small cell lung cancer; P53; Wnt7a

Indexed keywords

EID: 84970939143     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20134507     Document Type: Article

References (41)

1. Bao, B., Ahmad, A., Kong, D., Ali, S., Azmi, A. S., Li, Y., Banerjee, S., Padhye, S. and Sarkar, F. H. (2012). Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. PLoS ONE 7, e43726.
2. Baskerville, S. and Bartel, D. P. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247.
3. Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642.
4. Bikkavilli, R. K. and Malbon, C. C. (2010). Dishevelled-KSRP complex regulates Wnt signaling through post-transcriptional stabilization of beta-catenin mRNA. J. Cell Sci. 123, 1352-1362.
5. Bikkavilli, R. K. and Malbon, C. C. (2012). Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2. J. Cell Sci. 125, 2446-2456.
6. Cai, Y., Yu, X., Hu, S. and Yu, J. (2009). A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 7, 147-154.
7. Calin, G. A., Garzon, R., Cimmino, A., Fabbri, M. and Croce, C. M. (2006). MicroRNAs and leukemias: how strong is the connection? Leuk. Res. 30, 653-655.
8. Cameron, S. J., Malik, S., Akaike, M., Lerner-Marmarosh, N., Yan, C., Lee, J. D., Abe, J. and Yang, J. (2003). Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ ERK5 but not ERK1/2 kinase activation. J. Biol. Chem. 278, 18682-18688.
9. Clapé, C., Fritz, V., Henriquet, C., Apparailly, F., Fernandez, P. L., Iborra, F., Avancès, C., Villalba, M., Culine, S. and Fajas, L. (2009). miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE 4, e7542.
10. Esquela-Kerscher, A. and Slack, F. J. (2006). Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
11. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C. et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 104, 15805-15810.
12. Garzon, R., Fabbri, M., Cimmino, A., Calin, G. A. and Croce, C. M. (2006). MicroRNA expression and function in cancer. Trends Mol. Med. 12, 580-587.
13. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
14. Kamakura, S., Moriguchi, T. and Nishida, E. (1999). Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274, 26563-26571.
15. Karim, R., Tse, G., Putti, T., Scolyer, R. and Lee, S. (2004). The significance of the Wnt pathway in the pathology of human cancers. Pathology 36, 120-128.
16. Kole, A. J., Swahari, V., Hammond, S. M. and Deshmukh, M. (2011). miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 25, 125-130.
17. Lai, E. C., Tomancak, P., Williams, R. W. and Rubin, G. M. (2003). Computational identification of Drosophila microRNA genes. Genome Biol. 4, R42.
18. Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B. and Bartel, D. P. (2003a). Vertebrate microRNA genes. Science 299, 1540.
19. Lim, L. P., Lau, N. C., Weinstein, E. G., Abdelhakim, A., Yekta, S., Rhoades, M.W., Burge, C. B. and Bartel, D. P. (2003b). The microRNAs of Caenorhabditis elegans. Genes Dev. 17, 991-1008.
20. Malbon, C. C. (2005). G proteins in development. Nat. Rev. Mol. Cell Biol. 6, 689-701.
21. Mazieres, J., He, B., You, L., Xu, Z. and Jablons, D. M. (2005). Wnt signaling in lung cancer. Cancer Lett. 222, 1-10.
22. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O. and Clevers, H. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86, 391-399.
23. Oliver, T. G., Meylan, E., Chang, G. P., Xue, W., Burke, J. R., Humpton, T. J., Hubbard, D., Bhutkar, A. and Jacks, T. (2011). Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop. Mol. Cell 43, 57-71.
24. Peifer, M. and Polakis, P. (2000). Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287, 1606-1609.
25. Rom, W. N. and Tchou-Wong, K. M. (2003). Molecular and genetic aspects of lung cancer. Methods Mol. Med. 75, 3-26.
26. Rothschild, S. I., Tschan, M. P., Federzoni, E. A., Jaggi, R., Fey, M. F., Gugger, M. and Gautschi, O. (2012). MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene 31, 4221-4232.
27. Ru, P., Steele, R., Newhall, P., Phillips, N. J., Toth, K. and Ray, R. B. (2012). miRNA- 29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol. Cancer Ther. 11, 1166-1173.
28. Samakoglu, S., Deevi, D. S., Li, H., Wang, S., Murphy, M., Bao, C., Bassi, R., Prewett, M. and Tonra, J. R. (2012). Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. Cancer Genomics Proteomics 9, 77-92.
29. Sekido, Y., Fong, K. M. and Minna, J. D. (1998). Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta 1378, F21-F59.
30. Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M. and Gonzalez, F. J. (2007). Peroxisome proliferator-activated receptor alpha regulates a microRNAmediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol. 27, 4238-4247.
31. Siegel, R., Naishadham, D. and Jemal, A. (2013). Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30.
32. Tennis, M. A., Van Scoyk, M., Heasley, L. E., Vandervest, K., Weiser-Evans, M., Freeman, S., Keith, R. L., Simpson, P., Nemenoff, R. A. and Winn, R. A. (2010). Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1. Neoplasia 12, 244-253.
33. Wang, Y., Debatin, K. M. and Hug, H. (2001). HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels. BMC Mol. Biol. 2, 8.
34. Wang, J., Czech, B., Crunk, A., Wallace, A., Mitreva, M., Hannon, G. J. and Davis, R. E. (2011). Deep small RNA sequencing from the nematode Ascaris reveals conservation, functional diversification, and novel developmental profiles. Genome Res. 21, 1462-1477.
35. Winn, R. A. and Heasley, L. E. (2004). Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth. Chest 125 Suppl., 122S-123S.
36. Winn, R. A., Marek, L., Han, S. Y., Rodriguez, K., Rodriguez, N., Hammond, M., Van Scoyk, M., Acosta, H., Mirus, J., Barry, N. et al. (2005). Restoration of Wnt- 7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J. Biol. Chem. 280, 19625-19634.
37. Winn, R. A., Van Scoyk, M., Hammond, M., Rodriguez, K., Crossno, J. T., Jr, Heasley, L. E. and Nemenoff, R. A. (2006). Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 281, 26943-26950.
38. Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z. G. and Chopp, M. (2012). Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30, 1556-1564.
39. Yang, Y. M., Seo, S. Y., Kim, T. H. and Kim, S. G. (2012). Decrease of microRNA- 122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Hepatology 56, 2209-2220.
40. Zhan, C., Varney, K., Yuan, W., Zhao, L. and Lu, W. (2012). Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined. J. Am. Chem. Soc. 134, 6855-6864.
41. Zhang, J., Sun, Q., Zhang, Z., Ge, S., Han, Z. G. and Chen, W. T. (2013). Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32, 61-69.